These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19019090)

  • 21. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
    J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excavatolide B Attenuates Rheumatoid Arthritis through the Inhibition of Osteoclastogenesis.
    Lin YY; Jean YH; Lee HP; Lin SC; Pan CY; Chen WF; Wu SF; Su JH; Tsui KH; Sheu JH; Sung PJ; Wen ZH
    Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28067799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis.
    Hofkens W; Grevers LC; Walgreen B; de Vries TJ; Leenen PJ; Everts V; Storm G; van den Berg WB; van Lent PL
    J Control Release; 2011 Jun; 152(3):363-9. PubMed ID: 21396411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
    Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis.
    Kim JY; Lee EY; Lee EB; Lee YJ; Yoo HJ; Choi J; Song YW
    Arthritis Res Ther; 2012 Aug; 14(4):R187. PubMed ID: 22901757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
    Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
    Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
    Rahman MM; Bhattacharya A; Fernandes G
    J Lipid Res; 2006 Aug; 47(8):1739-48. PubMed ID: 16702601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis.
    Yokota K; Sato K; Miyazaki T; Aizaki Y; Tanaka S; Sekikawa M; Kozu N; Kadono Y; Oda H; Mimura T
    Arthritis Rheumatol; 2021 Jul; 73(7):1145-1154. PubMed ID: 33512089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
    Wittrant Y; Theoleyre S; Couillaud S; Dunstan C; Heymann D; Rédini F
    Exp Cell Res; 2004 Feb; 293(2):292-301. PubMed ID: 14729467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour necrosis factor α augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression.
    Oi K; Tokunaga T; Kuranobu T; Yukawa K; Kohno H; Yoshida Y; Mokuda S; Hirata S; Sugiyama E
    Clin Exp Immunol; 2019 Jun; 196(3):392-402. PubMed ID: 30724348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation.
    Mandelin J; Liljeström M; Li TF; Ainola M; Hukkanen M; Salo J; Santavirta S; Konttinen YT
    J Biomed Mater Res B Appl Biomater; 2005 Jul; 74(1):582-8. PubMed ID: 15768436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quercetin, a Plant Polyphenol, Has Potential for the Prevention of Bone Destruction in Rheumatoid Arthritis.
    Kim HR; Kim BM; Won JY; Lee KA; Ko HM; Kang YS; Lee SH; Kim KW
    J Med Food; 2019 Feb; 22(2):152-161. PubMed ID: 30596535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
    Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell leukemia translocation-associated gene (TCTA) protein is required for human osteoclastogenesis.
    Kotake S; Nanke Y; Kawamoto M; Yago T; Udagawa N; Ichikawa N; Kobashigawa T; Saito S; Momohara S; Kamatani N; Yamanaka H
    Bone; 2009 Oct; 45(4):627-39. PubMed ID: 19560569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
    Hase H; Kanno Y; Kojima H; Sakurai D; Kobata T
    Arthritis Rheum; 2008 Nov; 58(11):3356-65. PubMed ID: 18975335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes.
    Shinoda K; Sugiyama E; Taki H; Harada S; Mino T; Maruyama M; Kobayashi M
    Bone; 2003 Oct; 33(4):711-20. PubMed ID: 14555277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis.
    Kim HR; Kim KW; Kim BM; Cho ML; Lee SH
    PLoS One; 2015; 10(4):e0124909. PubMed ID: 25894998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.